Management of Pharmaceutical Wastes
Session 25: Management of Pharmaceutical Wastes
Total Session Time: 120 minutes
Pre-requisites
Learning Tasks
By the end of this session students are expected to be able to:
Resources Needed:
SESSION OVERVIEW
|Step |Time |Activity/ |Content |
| | |Method | |
|1 |05 minutes |Presentation |Introduction, Learning Tasks |
|2 |10 minutes |Buzzing |Definitions |
| | |Presentation | |
|3 | |Small group |Sources of Pharmaceutical Wastes |
| |35 minutes |discussion | |
| | |Presentation | |
|4 |30 Minutes |Presentation |Types of wastes produced during |
| | | |pharmaceutical production and their |
| | | |problems |
|5 |30 minutes |Presentation |Disposal of Pharmaceutical wastes |
|6 |05 minutes |Presentation |Key Points |
|7 |05 minutes |Presentation |Evaluation |
SESSION CONTENTS
STEP 1: Presentation of Session Title and Learning Tasks (5 minutes)
READ or ASK students to read the learning tasks and clarify
ASK students if they have any questions before continuing
STEP 2: Definitions (10 minutes)
|Activity: Buzzing (5 minutes) |
| |
|ASK students to pair up and buzz on the following question for 2 |
|minutes |
| |
|What is a pharmaceutical waste? |
| |
|ALLOW few pairs to respond and let other pairs to add on points not |
|mentioned |
| |
|WRITE their response on the flip chart/board |
| |
|CLARIFY and SUMMARIZE by using the content below |
manufacturing process that can eventually turn into hazardous or non
hazardous material to human or the environment or both
pharmaceutical production processes
manufacturing wastes and others
STEP 3: Sources of Pharmaceutical Wastes (35 minutes)
|Activity: Small Group Discussion (15 minutes) |
| |
|DIVIDE students into small manageable groups |
| |
|ASK students to discuss on the following question |
|What are the sources of waste in pharmaceutical manufacturing? |
| |
|ALLOW students to discuss for 15 minutes |
| |
|ALLOW few groups to present and the rest to add points not mentioned |
| |
|CLARIFY and SUMMARIZE by using the contents below |
o Wastes generated during pharmaceutical production
o Unusable/expired/rejected/obsolete raw materials
o Expired/unusable/rejected active pharmaceutical ingredients
o Rejected finished products
o Unusable or damaged packaging materials
o Used chemical by products
o Spills
o Unused/unusable solvents, chemicals and reagents
o Waste water
o Cleaning substances e.g. detergents, soaps
o Waste waster
STEP 4: Types of Wastes Produced in Pharmaceutical Production and their
Problems (30 minutes)
o Hazardous wastes
o Non-hazardous wastes
o Hazardous wastes
harmful to human health or environment
Ignitability
fire hazard under routine storage, disposal and transportation or
are capable of exacerbating a fire once it has started
Corrositity
metals or other materials or burn the skin
Reactivity
heated, compressed, or mixed with water
Toxicity
heavy metals such as chromium, lead, mercury or cadmium
Infectivity
vaccines or immunological preparations
o Non-hazardous wastes
no significant hazardous properties
health
|Activity: Small Group Discussion (15 minutes) |
| |
|DIVIDE students into small manageable groups |
| |
|ASK students to discuss on the following question |
|What are the problems associated with industrial pharmaceutical |
|wastes? |
| |
|ALLOW students to discuss for 15 minutes |
| |
|ALLOW few groups to present and the rest to add points not mentioned|
| |
| |
|CLARIFY and SUMMARIZE by using the contents below |
o Environmental contamination with drug substances
the environment
STEP 5: Disposal of Pharmaceutical Wastes (30 minutes)
o Incineration
(solid, liquid and gaseous waste), in which solid organic wastes
are subjected to combustion so as to convert them into residue and
gaseous products (heat, gas, steam and ash) by use of an
incinerator
and solid residue from waste water management
original volume
ash. Incineration is carried out both on a small scale by
individuals and on a large scale by industry
hazardous waste materials (such as biological waste)
o Deep burial
area that is not prone to flooding or erosion, and where the soil
is relatively impermeable, there are no inhabitants or shallow
wells in the vicinity, and the risk to surface water contamination
is remote
o Secure landfill
this remains a common practice in most countries
mining voids or borrow pits
and relatively inexpensive method of disposing of waste materials
number of adverse environmental impacts such as wind-blown litter,
attraction of vermin, and generation of liquid leachate
o Waste immobilization by encapsulation
solid block within a plastic or steel drum
contained explosive or hazardous materials previously
pharmaceuticals, and the remaining space is filled by pouring in a
medium such as cement or cement/lime mixture, plastic foam or
bituminous sand
o Waste immobilization by inertization
the packaging materials, paper, cardboard and plastic, from the
pharmaceuticals. Pills need to be removed from their blister packs
and lime added to form a homogenous paste
mixer truck to a landfill and decanted into the normal urban waste
municipal solid waste.
unsophisticated equipment
pharmaceuticals, a concrete mixer, and supplies of cement, lime and
water
o Sewer
fluids remains or unusable, can be diluted with water and flushed
into the sewers in small quantities over a period of time without
serious public health or environmental affect
quantities of well-diluted liquid pharmaceuticals or antiseptics
required in situations where sewers are in disrepair or have been
war damaged
o Waste minimization
of waste material being created
STEP 6: Key Points (5 minutes)
manufacturing process that can eventually turn into hazardous or non
hazardous material to human or the environment or both
manufacturing wastes, quality control laboratories, packaging materials,
raw materials and others
hazardous wastes
secure land fill and waste immobilization
STEP 7: Evaluation (5 minutes)
References
Aulton M.E & Kevin M.G, (Eds): (2013) Pharmaceutics: The design and
manufacture of medicines, (4th ed.) Churchill Livingstone
Hugo and Russell (2011), Pharmaceutical Microbiology (8th ed.), Willey-
Blackwel publications
Gennaro, R. A, et al. (Eds) (1995) Remington: The Science and Practice of
Pharmacy, Volume I & II, (19th ed.): Mack Publishing Company, Easton,
Pennsylvania 18042
Liebsch, B., et al. (1988): Tanzania Pharmaceutical Handbook, Dar es Salaam
University Press.
Lund, W. Editor (1994). The Pharmaceutical Codex, Principles and Practice
of Pharmaceutics (12th ed.): The Pharmaceutical Press, London
Polderman, J., (1990) Introduction to Pharmaceutical Production: Novib, The
Hague
Rawlins E.A, Editor: (1977) Bentley’s Textbook of Pharmaceutics, (8th ed.)
Baillie're Tindall. London Kamm, G. and Kohler, B. Editors: (1995)
Manual for Decentralized Infusion Production, Infusion Unit Project
Tanzania
Schmidt, O. (ed) (2000) Pharmaceutical Quality systems, Interpharm Press,
Colorado.
Shayne C et al. (2008), Pharmaceutical Manufacturing Handbook: Production
and processes, John Wiley & Sons
Watson, D. G,. (1999) Pharmaceutical Analysis: A Textbook for Pharmacy
Students and Pharmaceutical Chemists: Churchill Livingstone,
Edinburgh.
———————–
PST 06103 Pharmaceutical Production
NTA Level 6 Semester 1
March 2019
Source: Aulton 2013
Unataka kutumiwa notes hizi kupitia WhatsApp?Kwa notes zilizopangiliwa vizuri kwa kusoma offline au PDF, bonyeza kitufe hapa chini. Ujumbe wenye Level, Semester, Module na Topic utaandaliwa moja kwa moja.TUMIWA NOTES WHATSAPP